[A12-17] Pixantrone - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 01.03.2013
Project no.:
A12-17
Commission:
Commission awarded on 30.11.2012 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Cancer
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Federal Joint Committee (G-BA)
2013-05-16 A G-BA decision was published.